Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Pegvisomant | The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Carbutamide. |
| Carbocisteine | The risk or severity of adverse effects can be increased when Carbutamide is combined with Carbocisteine. |
| Chloramphenicol | The metabolism of Carbutamide can be decreased when combined with Chloramphenicol. |
| Cimetidine | The serum concentration of Carbutamide can be increased when it is combined with Cimetidine. |
| Fluconazole | The serum concentration of Carbutamide can be increased when it is combined with Fluconazole. |
| Metreleptin | Metreleptin may increase the hypoglycemic activities of Carbutamide. |
| Probenecid | The protein binding of Carbutamide can be decreased when combined with Probenecid. |
| Ranitidine | The serum concentration of Carbutamide can be increased when it is combined with Ranitidine. |
| Voriconazole | The serum concentration of Carbutamide can be increased when it is combined with Voriconazole. |
| Clarithromycin | The serum concentration of Carbutamide can be increased when it is combined with Clarithromycin. |
| Lipoic acid | The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Carbutamide. |
| Rifampin | The serum concentration of Carbutamide can be decreased when it is combined with Rifampicin. |
| Moxifloxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Moxifloxacin. |
| Grepafloxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Grepafloxacin. |
| Enoxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Enoxacin. |
| Pefloxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Pefloxacin. |
| Ciprofloxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Ciprofloxacin. |
| Trovafloxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Trovafloxacin. |
| Nalidixic acid | The therapeutic efficacy of Carbutamide can be increased when used in combination with Nalidixic acid. |
| Rosoxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Rosoxacin. |
| Cinoxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Cinoxacin. |
| Lomefloxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Lomefloxacin. |
| Gatifloxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Gatifloxacin. |
| Norfloxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Norfloxacin. |
| Levofloxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Levofloxacin. |
| Gemifloxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Gemifloxacin. |
| Ofloxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Ofloxacin. |
| Sparfloxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Sparfloxacin. |
| Temafloxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Temafloxacin. |
| Fleroxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Fleroxacin. |
| Technetium Tc-99m ciprofloxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Technetium Tc-99m ciprofloxacin. |
| Garenoxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Garenoxacin. |
| Nemonoxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Nemonoxacin. |
| Flumequine | The therapeutic efficacy of Carbutamide can be increased when used in combination with Flumequine. |
| Enrofloxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Enrofloxacin. |
| Orbifloxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Orbifloxacin. |
| Sarafloxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Sarafloxacin. |
| Difloxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Difloxacin. |
| Pazufloxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Pazufloxacin. |
| Prulifloxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Prulifloxacin. |
| Delafloxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Delafloxacin. |
| Sitafloxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Sitafloxacin. |
| Oxolinic acid | The therapeutic efficacy of Carbutamide can be increased when used in combination with Oxolinic acid. |
| Rufloxacin | The therapeutic efficacy of Carbutamide can be increased when used in combination with Rufloxacin. |
| Pipemidic acid | The therapeutic efficacy of Carbutamide can be increased when used in combination with Pipemidic acid. |
| Methyclothiazide | The therapeutic efficacy of Carbutamide can be decreased when used in combination with Methyclothiazide. |
| Chlorthalidone | The therapeutic efficacy of Carbutamide can be decreased when used in combination with Chlorthalidone. |
| Bendroflumethiazide | The therapeutic efficacy of Carbutamide can be decreased when used in combination with Bendroflumethiazide. |
| Metolazone | The therapeutic efficacy of Carbutamide can be decreased when used in combination with Metolazone. |
| Benzthiazide | The therapeutic efficacy of Carbutamide can be decreased when used in combination with Benzthiazide. |
| Hydroflumethiazide | The therapeutic efficacy of Carbutamide can be decreased when used in combination with Hydroflumethiazide. |
| Indapamide | The therapeutic efficacy of Carbutamide can be decreased when used in combination with Indapamide. |
| Chlorothiazide | The therapeutic efficacy of Carbutamide can be decreased when used in combination with Chlorothiazide. |
| Hydrochlorothiazide | The therapeutic efficacy of Carbutamide can be decreased when used in combination with Hydrochlorothiazide. |
| Trichlormethiazide | The therapeutic efficacy of Carbutamide can be decreased when used in combination with Trichlormethiazide. |
| Polythiazide | The therapeutic efficacy of Carbutamide can be decreased when used in combination with Polythiazide. |
| Quinethazone | The therapeutic efficacy of Carbutamide can be decreased when used in combination with Quinethazone. |
| Cyclopenthiazide | The therapeutic efficacy of Carbutamide can be decreased when used in combination with Cyclopenthiazide. |
| Epitizide | The therapeutic efficacy of Carbutamide can be decreased when used in combination with Epitizide. |
| Esmolol | Esmolol may increase the hypoglycemic activities of Carbutamide. |
| Landiolol | Landiolol may increase the hypoglycemic activities of Carbutamide. |
| Ethanol | The risk or severity of adverse effects can be increased when Carbutamide is combined with Ethanol. |
| Amitriptyline | Amitriptyline may decrease the hypoglycemic activities of Carbutamide. |
| Protriptyline | Protriptyline may decrease the hypoglycemic activities of Carbutamide. |
| Imipramine | Imipramine may decrease the hypoglycemic activities of Carbutamide. |
| Nortriptyline | Nortriptyline may decrease the hypoglycemic activities of Carbutamide. |
| Amoxapine | Amoxapine may decrease the hypoglycemic activities of Carbutamide. |
| Desipramine | Desipramine may decrease the hypoglycemic activities of Carbutamide. |
| Clomipramine | Clomipramine may decrease the hypoglycemic activities of Carbutamide. |
| Amineptine | Amineptine may decrease the hypoglycemic activities of Carbutamide. |
| Dimetacrine | Dimetacrine may decrease the hypoglycemic activities of Carbutamide. |
| Butriptyline | Butriptyline may decrease the hypoglycemic activities of Carbutamide. |
| Dosulepin | Dosulepin may decrease the hypoglycemic activities of Carbutamide. |
| Tianeptine | Tianeptine may decrease the hypoglycemic activities of Carbutamide. |
| Oxaprotiline | Oxaprotiline may decrease the hypoglycemic activities of Carbutamide. |
| Opipramol | Opipramol may decrease the hypoglycemic activities of Carbutamide. |
| Amitriptylinoxide | Amitriptylinoxide may decrease the hypoglycemic activities of Carbutamide. |
| Dibenzepin | Dibenzepin may decrease the hypoglycemic activities of Carbutamide. |
| Quinupramine | Quinupramine may decrease the hypoglycemic activities of Carbutamide. |
| Melitracen | Melitracen may decrease the hypoglycemic activities of Carbutamide. |
| Lofepramine | Lofepramine may decrease the hypoglycemic activities of Carbutamide. |
| Iprindole | Iprindole may decrease the hypoglycemic activities of Carbutamide. |
| Imipramine oxide | Imipramine oxide may decrease the hypoglycemic activities of Carbutamide. |
| Doxepin | Doxepin may decrease the hypoglycemic activities of Carbutamide. |
| Clofibrate | The risk or severity of hypoglycemia can be increased when Clofibrate is combined with Carbutamide. |
| Fenofibrate | The risk or severity of hypoglycemia can be increased when Fenofibrate is combined with Carbutamide. |
| Bezafibrate | The risk or severity of hypoglycemia can be increased when Bezafibrate is combined with Carbutamide. |
| Etofibrate | The risk or severity of hypoglycemia can be increased when Etofibrate is combined with Carbutamide. |
| Ciprofibrate | The risk or severity of hypoglycemia can be increased when Ciprofibrate is combined with Carbutamide. |
| Simfibrate | The risk or severity of hypoglycemia can be increased when Simfibrate is combined with Carbutamide. |
| Ronifibrate | The risk or severity of hypoglycemia can be increased when Ronifibrate is combined with Carbutamide. |
| Aluminium clofibrate | The risk or severity of hypoglycemia can be increased when Aluminium clofibrate is combined with Carbutamide. |
| Clofibride | The risk or severity of hypoglycemia can be increased when Clofibride is combined with Carbutamide. |
| Fenofibric acid | The risk or severity of hypoglycemia can be increased when Fenofibric acid is combined with Carbutamide. |
| Miconazole | The serum concentration of Carbutamide can be increased when it is combined with Miconazole. |
| Phenindione | Carbutamide may increase the anticoagulant activities of Phenindione. |
| Coumarin | Carbutamide may increase the anticoagulant activities of Coumarin. |
| (R)-warfarin | Carbutamide may increase the anticoagulant activities of (R)-warfarin. |
| Clorindione | Carbutamide may increase the anticoagulant activities of Clorindione. |
| Diphenadione | Carbutamide may increase the anticoagulant activities of Diphenadione. |